Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Other2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT02035683Not ApplicableUnknown
PET/CT Scan as a Tool to Rationalize the Treatment of of Advanced NSCLC Patients Undergoing First Chemotherapy
Non-small Cell Lung Cancer MetastaticNon-small Cell Lung Cancer Stage IIIB
Principalinvestigator

Research Network

Collaboration Network

27 collaborators·59 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Francesco Perrone, M.D., Ph.D

National Cancer Institute Naples, Italy; Director Clinical Trials Unit

Moderately Similar
9 trials

Shared therapeutic areas:

Non-small Cell Lung Cancer MetastaticNon-Small Cell Lung Cancer Stage IIIBColorectal Cancer Stage IV

Worked with same sponsors:

National Cancer Institute, Naples
Collaborated on 2 trials
Similarity Score38%

Ciro Gallo, M.D., Ph.D

Second University of Naples, Italy; Chair of Medical Statistics

Moderately Similar
8 trials

Shared therapeutic areas:

Non-small Cell Lung Cancer MetastaticNon-Small Cell Lung Cancer Stage IIIBColorectal Cancer Stage IV

Worked with same sponsors:

National Cancer Institute, Naples
Collaborated on 2 trials
Similarity Score38%

Massimo Di Maio, M.D.

National Cancer Institute, Naples

Related
5 trials

Shared therapeutic areas:

Non-small Cell Lung Cancer MetastaticNon-Small Cell Lung Cancer Stage IIIB

Worked with same sponsors:

National Cancer Institute, Naples
Collaborated on 1 trial
Similarity Score24%

Alessandro Morabito, M.D.

National Cancer Institute, Naples

Related
1 trials

Shared therapeutic areas:

Non-small Cell Lung Cancer MetastaticNon-Small Cell Lung Cancer Stage IIIB

Worked with same sponsors:

National Cancer Institute, Naples
Collaborated on 1 trial
Similarity Score24%

Gaetano Rocco, M.D.

National Cancer Institute, Naples

Related
1 trials

Shared therapeutic areas:

Non-small Cell Lung Cancer MetastaticNon-Small Cell Lung Cancer Stage IIIB

Worked with same sponsors:

National Cancer Institute, Naples
Collaborated on 1 trial
Similarity Score24%

Corradina Caracò, M.D.

National Cancer Institute, Naples

Related
1 trials

Shared therapeutic areas:

Colorectal Cancer Stage IV

Worked with same sponsors:

National Cancer Institute, Naples
Collaborated on 1 trial
Similarity Score14%

Francesco Izzo, M.D.

National Cancer Institute, Naples

Related
1 trials

Shared therapeutic areas:

Colorectal Cancer Stage IV

Worked with same sponsors:

National Cancer Institute, Naples
Collaborated on 1 trial
Similarity Score14%

Guglielmo Nasti, M.D.

National Cancer Institute, Naples

Related
1 trials

Shared therapeutic areas:

Colorectal Cancer Stage IV

Worked with same sponsors:

National Cancer Institute, Naples
Collaborated on 1 trial
Similarity Score14%

Giovanni Romano, M.D.

National Cancer Institute, Naples

Related
1 trials

Shared therapeutic areas:

Colorectal Cancer Stage IV

Worked with same sponsors:

National Cancer Institute, Naples
Collaborated on 1 trial
Similarity Score14%

Luigi Aloj, M.D.

National Cancer Institute, Naples

Related
1 trials

Shared therapeutic areas:

Colorectal Cancer Stage IV

Worked with same sponsors:

National Cancer Institute, Naples
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT02035683Not ApplicablePrincipalInvestigator

PET/CT Scan as a Tool to Rationalize the Treatment of of Advanced NSCLC Patients Undergoing First Chemotherapy

Non-small Cell Lung Cancer MetastaticNon-small Cell Lung Cancer Stage IIIB
Unknown
NCT02618850Not ApplicablePrincipalInvestigator

PET/CT Scan as a Tool to Rationalize the Treatment of Patients With Advanced ColoRectal Cancer Undergoing First-line Medical Treatment

Colorectal Cancer Stage IV
Unknown

All 2 trials loaded